Feng, W., Dean, D. C., Hornicek, F. J., Spentzos, D., Hoffman, R. M., Shi, H., & Duan, Z. (2020). Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma. Ther Adv Med Oncol.

Feng, Wenlong, Dylan C. Dean, Francis J. Hornicek, Dimitrios Spentzos, Robert M. Hoffman, Huirong Shi, und Zhenfeng Duan. "Myc Is a Prognostic Biomarker and Potential Therapeutic Target in Osteosarcoma." Ther Adv Med Oncol 2020.

Feng, Wenlong, et al. "Myc Is a Prognostic Biomarker and Potential Therapeutic Target in Osteosarcoma." Ther Adv Med Oncol 2020.